Aging, Neurocognition, and Medication Adherence in HIV Infection
- 1 April 2009
- journal article
- research article
- Published by Elsevier in American Journal of Geriatric Psychiatry
- Vol. 17 (4) , 281-290
- https://doi.org/10.1097/jgp.0b013e31819431bd
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Blood–brain barrier P-glycoprotein function decreases in specific brain regions with aging: A possible role in progressive neurodegenerationNeurobiology of Aging, 2008
- Role of psychiatric medications as adjunct therapy in the treatment of HIV associated neurocognitive disordersInternational Review of Psychiatry, 2008
- Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous SystemArchives of Neurology, 2008
- Prevalence of cognitive disorders differs as a function of age in HIV virus infectionAIDS, 2004
- Effects of HIV-1 infection and aging on neurobehavioral functioningAIDS, 2004
- Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease.Health Psychology, 2000
- Reaction Times are Faster in HIV-Seropositive Patients on Antiretroviral Therapy: A Preliminary ReportJournal of Clinical and Experimental Neuropsychology, 1999
- Effect of combination therapy with zidovudine and didanosine on neuropsychological functioning in patients with symptomatic HIV diseaseAIDS, 1997
- Neuropsychological performance and cd4 levels in HIV-1 asymptomatic infectionJournal of Clinical and Experimental Neuropsychology, 1994
- Three tests of attention and rapid information processing: An extensionThe Clinical Neuropsychologist, 1988